| 1. |
- Norén, Bengt, 1955-, et al.
(författare)
-
Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease
- 2005
-
Ingår i: European Radiology. - : Springer Science and Business Media LLC. - 0938-7994 .- 1432-1084. ; 15:1, s. 148-157
-
Tidskriftsartikel (refereegranskat)abstract
- Phosphorus-31 NMR spectroscopy using slice selection (DRESS) was used to investigate the absolute concentrations of metabolites in the human liver. Absolute concentrations provide more specific biochemical information compared to spectrum integral ratios. Nine patients with histopathologically proven diffuse liver disease and 12 healthy individuals were examined in a 1.5-T MR scanner (GE Signa LX Echospeed plus). The metabolite concentration quantification procedures included: (1) determination of optimal depth for the in vivo measurements, (2) mapping the detection coil characteristics, (3) calculation of selected slice and liver volume ratios using simple segmentation procedures and (4) spectral analysis in the time domain. The patients had significantly lower concentrations of phosphodiesters (PDE), 6.3±3.9 mM, and ATP-β, 3.6±1.1 mM, (P<0.05) compared with the control group (10.0±4.2 mM and 4.2±0.3 mM, respectively). The concentrations of phosphomonoesters (PME) were higher in the patient group, although this was not significant. Constructing an anabolic charge (AC) based on absolute concentrations, [PME]/([PME] + [PDE]), the patients had a significantly larger AC than the control subjects, 0.29 vs. 0.16 (P<0.005). Absolute concentration measurements of phosphorus metabolites in the liver are feasible using a slice selective sequence, and the technique demonstrates significant differences between patients and healthy subjects.
|
|
| 2. |
- Norén, Bengt, 1955-
(författare)
-
Quantitative 31P magnetic resonance spectroscopy in diffuse liver disease
- 2006
-
Licentiatavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The studies in this thesis were delineated to evaluate the diagnostic possibilities in patients with diffuse liver disease by using phosphorus-31 MR spectroscopy and comparing the results with clinical, laboratory and histopathological findings. For this purpose in all 38 patients and 25 controls without evidence of liver disease were examined.In the first study 31P-MRS using slice selection (DRESS) was implemented to investigate the absolute concentrations of metabolites in human liver. The metabolite concentration quantification procedures included: 1. Determination of optimal depth for the in vivo measurements, 2. Mapping the detection coil characteristics, 3. Calculation of selected slice and liver volume ratios using simple segmentation procedures, and 4. Spectral analysis in the time domain. Patients with histopathologically proven diffuse liver disease (n = 9) and healthy individuals (n = 12) were examined. The patients had significantly lower concentrations of phosphodiesters (PDE) and ATP-ß compared with the control group. Constructing an anabolic charge (AC) based on absolute concentrations, [PME] / ([PME] + [PDE]), the patients had a significant larger AC than the control subjects, 0.29 vs. 0.16 (p < 0.005).In the second study the MRS technique was applied on two distinct groups of patients with diffuse chronic liver disorders, one group with steatosis and none-to-moderate inflammation (n = 13) and one group with severe fibrosis or cirrhosis (n = 16). All patients underwent liver biopsy and extensive biochemical evaluation. A control group (n = 13) was also included. Lower concentrations of PDE (p = 0.025) and a higher AC (p = 0.001) were found in the cirrhosis group compared to the control group.Using a PDE concentration of 10.5 mM as a cut-off value to discriminate between mild (stage 0-2) and advanced (stage 3-4) fibrosis the sensitivity and specificity were 81% and 69% respectively. An AC cut-off value of 0.27 showed a sensitivity of 93% and a specificity of 54%.In conclusion the results indicates that a decrease in PDE concentration is a marker of liver fibrosis and that AC is a potentially clinically useful parameter indiscriminating mild fibrosis from advanced. No significant relationship between the MRS data and the degree of steatosis or inflammation was found.
|
|
| 3. |
- Norén, Bengt, 1955-, et al.
(författare)
-
Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy
- 2008
-
Ingår i: European Journal of Radiology. - : Elsevier. - 0720-048X .- 1872-7727. ; 66:2, s. 313-320
-
Tidskriftsartikel (refereegranskat)abstract
- 31P-MRS using DRESS was used to compare absolute liver metabolite concentrations (PME, Pi, PDE, γATP, αATP, βATP) in two distinct groups of patients with chronic diffuse liver disorders, one group with steatosis (NAFLD) and none to moderate inflammation (n = 13), and one group with severe fibrosis or cirrhosis (n = 16). All patients underwent liver biopsy and extensive biochemical evaluation. A control group (n = 13) was also included. Absolute concentrations and the anabolic charge, AC = {PME}/({PME} + {PDE}), were calculated.Comparing the control and cirrhosis groups, lower concentrations of PDE (p = 0.025) and a higher AC (p < 0.001) were found in the cirrhosis group. Also compared to the NAFLD group, the cirrhosis group had lower concentrations of PDE (p = 0.01) and a higher AC (p = 0.009). No significant differences were found between the control and NAFLD group. When the MRS findings were related to the fibrosis stage obtained at biopsy, there were significant differences in PDE between stage F0–1 and stage F4 and in AC between stage F0–1 and stage F2–3.Using a PDE concentration of 10.5 mM as a cut-off value to discriminate between mild, F0–2, and advanced, F3–4, fibrosis the sensitivity and specificity were 81% and 69%, respectively. An AC cut-off value of 0.27 showed a sensitivity of 93% and a specificity of 54%.In conclusion, the results suggest that PDE is a marker of liver fibrosis, and that AC is a potentially clinically useful parameter in discriminating mild fibrosis from advanced.
|
|
| 4. |
- Sörstedt, Erik, 1980-, et al.
(författare)
-
Computed tomographic colonography : Comparison of two workstations
- 2005
-
Ingår i: Acta Radiologica. - : SAGE Publications. - 0284-1851 .- 1600-0455. ; 46:7, s. 671-678
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose: To compare two commercially available computed tomography (CT) colonography systems with respect to interobserver variability, the influence of level of expertise, and the gradual reduction of reviewing time for each system. Material and Methods: Two residents and two radiologists using Siemens CTAPP Colography software and Viatronix V3DColon software reviewed supine and prone CT acquisitions from 24 patients in a primary 3D endoluminal view. The observers graded each case with respect to technical quality and diagnostic value, assessed the presence of pathology, and indicated the time spent on the viewing. Results: Significant differences were found in technical quality ( P <0.001) and diagnostic value ( P <0.001) depending on which system was used, with higher scores for the Viatronix software. The agreement between specialists tended to be higher than that between residents (κ = 0.63 (0.30-0.95) vs. κ = 0.51 (0.21-0.81)), and the residents gave significantly ( P <0.001) higher scores of technical quality. However, the level of expertise had no significant impact on the assessments. We noted extensive variability in pathological lesions found by the different observers. The number of findings did not differ between workstations, but the viewers tended to report larger polyp sizes with the Viatronix software. The time needed for viewing decreased significantly from the first to the last examination viewed by each observer. Conclusion: Both the evaluated systems present trustworthy images of the human colon, but in a primary 3D setting the Viatronix software is favored owing to the userfriendly interface, higher experienced technical quality, and better diagnostic value. © 2005 Taylor & Francis.
|
|
